HABP2
Basic information
Region (hg38): 10:113550837-113589602
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Thyroid cancer, nonmedullary 5 | AD | Oncologic | Individuals have been described as being susceptible to nonmedullary thyroid cancer, and awareness may allow early surveillance, diagnosis, and management | Oncologic | 26222560 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HABP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 19 | ||||
missense | 72 | 10 | 82 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 32 | 29 | 46 | 107 | ||
Total | 0 | 0 | 116 | 44 | 50 |
Variants in HABP2
This is a list of pathogenic ClinVar variants found in the HABP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-113552847-G-A | Benign (Jan 10, 2019) | |||
10-113553047-AT-A | Factor VII Marburg I Variant Thrombophilia | Uncertain significance (Jun 14, 2016) | ||
10-113553051-T-C | Factor VII Marburg I Variant Thrombophilia | Likely benign (Feb 14, 2020) | ||
10-113553052-T-C | Factor VII Marburg I Variant Thrombophilia | Benign/Likely benign (Jan 10, 2019) | ||
10-113553057-C-G | Factor VII Marburg I Variant Thrombophilia | Uncertain significance (Jan 13, 2018) | ||
10-113553064-G-C | Factor VII Marburg I Variant Thrombophilia | Likely benign (Feb 28, 2019) | ||
10-113553119-A-G | Factor VII Marburg I Variant Thrombophilia | Likely benign (Mar 01, 2024) | ||
10-113553136-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
10-113553167-C-G | Factor VII Marburg I Variant Thrombophilia | Likely benign (Mar 06, 2018) | ||
10-113553178-G-T | not specified | Uncertain significance (Jan 25, 2023) | ||
10-113553180-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
10-113553184-C-T | Factor VII Marburg I Variant Thrombophilia | Uncertain significance (Jan 13, 2018) | ||
10-113567180-C-A | Benign (Jan 10, 2019) | |||
10-113567186-G-A | Benign (Jan 10, 2019) | |||
10-113567191-C-G | Benign (Jan 10, 2019) | |||
10-113567281-A-G | Benign (Jan 10, 2019) | |||
10-113567289-C-G | Benign (Jan 10, 2019) | |||
10-113567312-G-A | Benign (Jan 10, 2019) | |||
10-113567325-A-G | Benign (Jan 10, 2019) | |||
10-113567434-A-G | Benign (Jan 10, 2019) | |||
10-113567446-G-C | Likely benign (May 26, 2021) | |||
10-113567499-T-G | not specified | Uncertain significance (Aug 02, 2022) | ||
10-113567502-C-G | Uncertain significance (-) | |||
10-113567504-T-G | not specified | Uncertain significance (Jan 31, 2022) | ||
10-113567514-G-T | Factor VII Marburg I Variant Thrombophilia | Likely benign (Feb 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HABP2 | protein_coding | protein_coding | ENST00000351270 | 13 | 38766 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.96e-15 | 0.0547 | 125050 | 3 | 695 | 125748 | 0.00278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.43 | 385 | 314 | 1.23 | 0.0000160 | 3726 |
Missense in Polyphen | 127 | 106.93 | 1.1876 | 1298 | ||
Synonymous | -1.34 | 140 | 121 | 1.16 | 0.00000683 | 997 |
Loss of Function | 0.690 | 25 | 29.0 | 0.862 | 0.00000123 | 362 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00451 | 0.00451 |
Ashkenazi Jewish | 0.00616 | 0.00617 |
East Asian | 0.000382 | 0.000381 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00383 | 0.00382 |
Middle Eastern | 0.000382 | 0.000381 |
South Asian | 0.000459 | 0.000457 |
Other | 0.00555 | 0.00555 |
dbNSFP
Source:
- Function
- FUNCTION: Cleaves the alpha-chain at multiple sites and the beta- chain between 'Lys-53' and 'Lys-54' but not the gamma-chain of fibrinogen and therefore does not initiate the formation of the fibrin clot and does not cause the fibrinolysis directly. It does not cleave (activate) prothrombin and plasminogen but converts the inactive single chain urinary plasminogen activator (pro- urokinase) to the active two chain form. Activates coagulation factor VII (PubMed:8827452, PubMed:10754382, PubMed:11217080). May function as a tumor suppressor negatively regulating cell proliferation and cell migration (PubMed:26222560). {ECO:0000269|PubMed:10754382, ECO:0000269|PubMed:11217080, ECO:0000269|PubMed:26222560, ECO:0000269|PubMed:8827452}.;
- Disease
- DISEASE: Thyroid cancer, non-medullary, 5 (NMTC5) [MIM:616535]: A form of non-medullary thyroid cancer (NMTC), a cancer characterized by tumors originating from the thyroid follicular cells. NMTCs represent approximately 95% of all cases of thyroid cancer and are classified into papillary, follicular, Hurthle cell, and anaplastic neoplasms. {ECO:0000269|PubMed:12578864, ECO:0000269|PubMed:26222560}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.123
- rvis_EVS
- -0.06
- rvis_percentile_EVS
- 48.89
Haploinsufficiency Scores
- pHI
- 0.454
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.399
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0875
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Habp2
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- proteolysis;cell adhesion
- Cellular component
- extracellular region;extracellular space
- Molecular function
- serine-type endopeptidase activity;calcium ion binding;glycosaminoglycan binding